Brief: Cross Country Healthcare Q3 Adjusted EPS USD 0.03 Vs. IBES Estimate USD 0.04
12/11/2025 21:56
Nov 12 (Reuters) - Cross Country Healthcare Q3 adjusted EBITDA USD 6.524 million vs. IBES estimate USD 7.47 million. Q3 net income USD -4.774 million Q3 adjusted EBITDA margin 2.6% Q3 EPS USD -0.15 Q3 gross margin 20.4% Q3 revenue USD 250.052 million vs. IBES estimate USD 270.8 million
Recent news on Cross Country Healthcare
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Cross Country Healthcare Q1 revenue falls 18% but beats estimates
Brief: Cross Country Healthcare Q1 Adjusted EPS USD -0.03 Vs. IBES Estimate USD -0.04
Brief: Cross Country Healthcare To Be Acquired By Knox Lane In All-Cash Transaction Valued At $437 Million